Vir Biotechnology Inc.

11/18/2024 | Press release | Distributed by Public on 11/18/2024 15:07

Vir Biotechnology Receives Positive Opinion on Orphan Drug Designation for Tobevibart and Elebsiran in Chronic Hepatitis Delta from European Medicines Agency